Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency

INTRODUCTION: Older patients with type 2 diabetes (T2D) are at increased risk of diabetic nephropathy and mild renal insufficiency. This analysis compared the anti-hyperglycemic efficacy and safety of sitagliptin with dapagliflozin in patients ≥ 65 years of age with T2D and mild renal insufficiency....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Ther
Главные авторы: Raji, Annaswamy, Xu, Zhi Jin, Lam, Raymond L. H., O’Neill, Edward A., Kaufman, Keith D., Engel, Samuel S.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Healthcare 2020
Предметы:
Brief Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509009/
https://ncbi.nlm.nih.gov/pubmed/32852696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00907-w
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы